There could soon be a new vaccine available – and it works in a completely different way than the others currently being used.
The US pharmaceutical company Novavax has put forward its Covid jab, Nuvaxovid for approval by Swissmedic.
The new drug will be the first protein vaccine available in the country. It contains a coronavirus spike protein which triggers the immune system.
In trials in the US and the UK, results suggest it provides a protection level of around 90%.
It does have another major advantage. It can be kept in a fridge for six months which makes distribution much easier.
Major 5 year works plan starts in Geneva next year
Home owner tax on brink of abolishment - or not
Boy killed by bus in Vaud
Quagga mussel found in Lake Zurich for first time
Police officer pardoned of speeding
Final - Geneva shops will open this Sunday
